News & Views

Interpreting hereditary gastrointestinal cancer genetic testing results: What today’s health care professional needs to know

Dr. Jatin P. Shah, HNCA board member and oncologist at Memorial Sloan Kettering Cancer Center collaborated with Sir H. N. Reliance Foundation Hospital and Research Centre in Mumbai, India to “bring the finest care to the patients suffering from mouth and throat cancer.

HNCA ambassador, Stewart Lyman, launched his counter-narrative to the anti-vaccine movement. His Scientific American opinion piece, “While Searching for the Perfect Vaccine, Keep Using the Very Good”, describes just how valuable vaccines are, and how the anti-vaccine movement has failed to live up to its own distorted rhetoric.

HNCA Chairman, Dr. Terry Day, had a Q&A on HPV and head and neck cancer featured in MUSC’s newsletter

2020 Oral Head and Neck Cancer Awareness® Program Spokesperson and voice actor, Rob Paulsen shares his cancer experience and advice for other individuals who may face a similar diagnosis with Heal® Magazine.

HNCA Ambassador and HPV-related tonsil cancer survivor, Stewart Lyman, PhD was awarded the 2020 Immunization Action Coalition of Washington (IACW) Award.

HNCA Board member, medical oncologist, professor, and director of the Center for Disease Prevention Research at the Medical College of Wisconsin, Stuart Wong, MD, was interviewed by Targeted Oncology on KEYNOTE-048 trial during Head and Neck Cancer Awareness Month.

Officer of the Board and HPV-related tonsil cancer survivor, Jason Mendelsohn and board member, Carole Fakhry, M.D., M.P.H., were featured in National Cancer Institute’s latest article on different treatments for oropharyngeal cancer.

HNCA President, associate professor of otolaryngology-head and neck surgery and chief of head and neck surgery at Indiana University School of Medicine, Dr. Michael Moore, was featured in CURE’s magazine to discuss immunotherapy options for head and neck cancer.

来源：中国科学报

来源：新华网

尚待观察，靶向化疗法可剿灭大多数实体肿瘤